The clinical relevance of long non-coding RNAs in cancer

Cancers

Volumn 7, Issue 4, 2015, Pages 2169-2182

  Silva, Andreia ^a,b,c,d   Bullock, Marc ^a,e,f   Calin, George ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF PORTO   (Portugal)

^c INEB INSTITUTO DE ENGENHARIA BIOMÉDICA   (Portugal)

^d UNIVERSITY OF PORTO   (Portugal)

^e UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^f UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Biomarker; Cancer diagnosis; Cancer prognosis; Circulating lncRNAs; Exosomes; Sensitivity; Specificity

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BIOLOGICAL MARKER; DIPHTHERIA TOXIN; HOX TRANSCRIPT ANTISENSE RNA; LONG UNTRANSLATED RNA; METASTASIS ASSOCIATED LUNG ADENOCARCINOMA TRANSCRIPT 1; PROTEIN PCGEM1; RNA H19; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

BODY FLUID; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER SURVIVAL; EXOSOME; GENE EXPRESSION; GENE TARGETING; HUMAN; METASTASIS; PANCREAS CANCER; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); REVIEW; RNA DEGRADATION; RNA TRANSCRIPTION; SENSITIVITY AND SPECIFICITY; UPREGULATION;

EID: 84945934720     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers7040884     Document Type: Review

References (81)

1. Mattick, J.S.; Makunin, I.V. Non-coding RNA. Hum. Mol. Genet. 2006, 15, R17-R29. [CrossRef] [PubMed]
2. Kaikkonen, M.U.; Lam, M.T.Y.; Glass, C.K. Non-coding RNAs as regulators of gene expression and epigenetics. Cardiovasc. Res. 2011, 90, 430-440. [CrossRef] [PubMed]
3. Laurent, G.; Wahlestedt, C.; Kapranov, P. The Landscape of long noncoding RNA classification. Trends Genet. TIG 2015, 31, 239-251. [CrossRef] [PubMed]
4. Cunningham, F.; Amode, M.R.; Barrell, D.; Beal, K.; Billis, K.; Brent, S.; Carvalho-Silva, D.; Clapham, P.; Coates, G.; Fitzgerald, S., et al. Ensembl 2015. Nucleic Acids Res. 2015, 43, D662-D669. [CrossRef] [PubMed]
5. Harrow, J.; Frankish, A.; Gonzalez, J.M.; Tapanari, E.; Diekhans, M.; Kokocinski, F.; Aken, B.L.; Barrell, D.; Zadissa, A.; Searle, S., et al. GENCODE: The reference human genome annotation for The ENCODE Project. Genome Res. 2012, 22, 1760-1774. [CrossRef] [PubMed]
6. Derrien, T.; Johnson, R.; Bussotti, G.; Tanzer, A.; Djebali, S.; Tilgner, H.; Guernec, G.; Martin, D.; Merkel, A.; Knowles, D.G., et al. The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression. Genome Res. 2012, 22, 1775-1789. [CrossRef] [PubMed]
7. Ponting, C.P.; Oliver, P.L.; Reik, W. Evolution and Functions of Long Noncoding RNAs. Cell 2009, 136, 629-641. [CrossRef] [PubMed]
8. Khalil, A.M.; Guttman, M.; Huarte, M.; Garber, M.; Raj, A.; Rivea Morales, D.; Thomas, K.; Presser, A.; Bernstein, B.E.; van Oudenaarden, A.; et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc. Natl. Acad. Sci. USA 2009, 106, 11667-11672. [CrossRef] [PubMed]
9. Feng, J.; Bi, C.; Clark, B.S.; Mady, R.; Shah, P.; Kohtz, J.D. The Evf-2 noncoding RNA is transcribed from the Dlx-5/6 ultraconserved region and functions as a Dlx-2 transcriptional coactivator. Genes Dev. 2006, 20, 1470-1484. [CrossRef] [PubMed]
10. Arab, K.; Park, Y.J.; Lindroth, A.M.; Schäfer, A.; Oakes, C.; Weichenhan, D.; Lukanova, A.; Lundin, E.; Risch, A.; Meister, M., et al. Long noncoding RNA TARID directs demethylation and activation of the tumor suppressor TCF21 via GADD45A. Mol. Cell 2014, 55, 604-614. [CrossRef] [PubMed]
11. Martianov, I.; Ramadass, A.; Serra Barros, A.; Chow, N.; Akoulitchev, A. Repression of the human dihydrofolate reductase gene by a non-coding interfering transcript. Nature 2007, 445, 666-670. [CrossRef] [PubMed]
12. Tripathi, V.; Ellis, J.D.; Shen, Z.; Song, D.Y.; Pan, Q.; Watt, A.T.; Freier, S.M.; Bennett, C.F.; Sharma, A.; Bubulya, P.A., et al. The Nuclear-Retained Noncoding RNA MALAT1 Regulates Alternative Splicing by Modulating SR Splicing Factor Phosphorylation. Mol. Cell 2010, 39, 925-938. [CrossRef] [PubMed]
13. Faghihi, M.A.; Modarresi, F.; Khalil, A.M.; Wood, D.E.; Sahagan, B.G.; Morgan, T.E.; Finch, C.E.; Laurent, G.; Kenny, P.J.; Wahlestedt, C. Expression of a noncoding RNA is elevated in Alzheimer’s disease and drives rapid feed-forward regulation of beta-secretase. Nat. Med. 2008, 14, 723-730. [CrossRef] [PubMed]
14. Gong, C.; Maquat, L.E. lncRNAs transactivate STAU1-mediated mRNA decay by duplexing with 31 UTRs via Alu elements. Nature 2011, 470, 284-288. [CrossRef] [PubMed]
15. Yoon, J.-H.; Abdelmohsen, K.; Srikantan, S.; Yang, X.; Martindale, J.L.; de, S.; Huarte, M.; Zhan, M.; Becker, K.G.; Gorospe, M. LincRNA-p21 suppresses target mRNA translation. Mol. Cell 2012, 47, 648-655. [CrossRef] [PubMed]
16. Carrieri, C.; Cimatti, L.; Biagioli, M.; Beugnet, A.; Zucchelli, S.; Fedele, S.; Pesce, E.; Ferrer, I.; Collavin, L.; Santoro, C., et al. Long non-coding antisense RNA controls Uchl1 translation through an embedded SINEB2 repeat. Nature 2012, 491, 454-457. [CrossRef] [PubMed]
17. Pauli, A.; Rinn, J.L.; Schier, A.F. Non-coding RNAs as regulators of embryogenesis. Nat. Rev. Genet. 2011, 12, 136-149. [CrossRef] [PubMed]
18. Fatica, A.; Bozzoni, I. Long non-coding RNAs: New players in cell differentiation and development. Nat. Rev. Genet. 2014, 15, 7-21. [CrossRef] [PubMed]
19. Tye, C.E.; Gordon, J.A.R.; Martin-Buley, L.A.; Stein, J.L.; Lian, J.B.; Stein, G.S. Could lncRNAs be the missing links in control of mesenchymal stem cell differentiation? J. Cell. Physiol. 2015, 230, 526-534. [CrossRef] [PubMed]
20. Satpathy, A.T.; Chang, H.Y. Long Noncoding RNA in hematopoiesis and immunity. Immunity 2015, 42, 792-804. [CrossRef] [PubMed]
21. Heward, J.A.; Lindsay, M.A. Long non-coding RNAs in the regulation of the immune response. Trends Immunol. 2014, 35, 408-419. [CrossRef] [PubMed]
22. Pastori, C.; Wahlestedt, C. Involvement of long noncoding RNAs in diseases affecting the central nervous system. RNA Biol. 2012, 9, 860-870. [CrossRef] [PubMed]
23. Schonrock, N.; Harvey, R.P.; Mattick, J.S. Long Noncoding RNAs in cardiac development and pathophysiology. Circ. Res. 2012, 111, 1349-1362. [CrossRef] [PubMed]
24. Kim, J.; Kim, K.M.; Noh, J.H.; Yoon, J.-H.; Abdelmohsen, K.; Gorospe, M. Long noncoding RNAs in diseases of aging. Biochim. Biophys. Acta 2015. in press. [CrossRef] [PubMed]
25. Zhao, Z.; Chen, C.; Liu, Y.; Wu, C. 17-Estradiol treatment inhibits breast cell proliferation, migration and invasion by decreasing MALAT-1 RNA level. Biochem. Biophys. Res. Commun. 2014, 445, 388-393. [CrossRef] [PubMed]
26. Yang, M.-H.; Hu, Z.-Y.; Xu, C.; Xie, L.-Y.; Wang, X.-Y.; Chen, S.-Y.; Li, Z.-G. MALAT1 promotes colorectal cancer cell proliferation/migration/invasion via PRKA kinase anchor protein 9. Biochim. Biophys. Acta 2015, 1852, 166-174. [CrossRef] [PubMed]
27. Hu, L.; Wu, Y.; Tan, D.; Meng, H.; Wang, K.; Bai, Y.; Yang, K. Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma. J. Exp. Clin. Cancer Res. CR 2015, 34. [CrossRef] [PubMed]
28. Hirata, H.; Hinoda, Y.; Shahryari, V.; Deng, G.; Nakajima, K.; Tabatabai, Z.L.; Ishii, N.; Dahiya, R. Long Noncoding RNA MALAT1 promotes aggressive renal cell carcinoma through Ezh2 and interacts with miR-205. Cancer Res. 2015, 75, 1322-1331. [CrossRef] [PubMed]
29. Michalik, K.M.; You, X.; Manavski, Y.; Doddaballapur, A.; Zörnig, M.; Braun, T.; John, D.; Ponomareva, Y.; Chen, W.; Uchida, S., et al. Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth. Circ. Res. 2014, 114, 1389-1397. [CrossRef] [PubMed]
30. Gupta, R.A.; Shah, N.; Wang, K.C.; Kim, J.; Horlings, H.M.; Wong, D.J.; Tsai, M.-C.; Hung, T.; Argani, P.; Rinn, J.L., et al. Long noncoding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010, 464, 1071-1076. [CrossRef] [PubMed]
31. Zhang, Z.-Z.; Shen, Z.-Y.; Shen, Y.-Y.; Zhao, E.-H.; Wang, M.; Wang, C.-J.; Cao, H.; Xu, J. HOTAIR Long Noncoding RNA promotes gastric cancer metastasis through suppression of poly r(C)-binding protein (PCBP) 1. Mol. Cancer Ther. 2015, 14, 1162-1170. [CrossRef] [PubMed]
32. Liu, X.; Liu, Z.; Sun, M.; Liu, J.; Wang, Z.; De, W. The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancer. BMC Cancer 2013, 13. [CrossRef] [PubMed]
33. Pádua Alves, C.; Fonseca, A.S.; Muys, B.R.; de Barros E.; Lima Bueno, R.; Bürger, M.C.; de Souza, J.E.S.; Valente, V.; Zago, M.A.; Silva, W.A. The lincRNA Hotair is required for epithelial-to-mesenchymal transition and stemness maintenance of cancer cell lines. Stem Cells Dayt. Ohio 2013, 31, 2827-2832. [CrossRef] [PubMed]
34. Pickard, M.R.; Williams, G.T. Molecular and cellular mechanisms of action of tumour suppressor GAS5 LncRNA. Genes 2015, 6, 484-499. [CrossRef] [PubMed]
35. Hung, C.-L.; Wang, L.-Y.; Yu, Y.-L.; Chen, H.-W.; Srivastava, S.; Petrovics, G.; Kung, H.-J. A long noncoding RNA connects c-Myc to tumor metabolism. Proc. Natl. Acad. Sci. USA 2014, 111, 18697-18702. [CrossRef] [PubMed]
36. Zhang, J.; Zhang, B.; Wang, T.; Wang, H. LncRNA MALAT1 overexpression is an unfavorable prognostic factor in human cancer: Evidence from a meta-analysis. Int. J. Clin. Exp. Med. 2015, 8, 5499-5505. [PubMed]
37. Zheng, H.-T.; Shi, D.-B.; Wang, Y.-W.; Li, X.-X.; Xu, Y.; Tripathi, P.; Gu, W.-L.; Cai, G.-X.; Cai, S.-J. High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer. Int. J. Clin. Exp. Pathol. 2014, 7, 3174-3181. [PubMed]
38. Yu, X.; Li, Z. Long non-coding RNA HOTAIR: A novel oncogene (Review). Mol. Med. Rep. 2015, 12, 5611-5618. [CrossRef] [PubMed]
39. Cai, B.; Wu, Z.; Liao, K.; Zhang, S. Long noncoding RNA HOTAIR can serve as a common molecular marker for lymph node metastasis: A meta-analysis. Tumor Biol. 2014, 35, 8445-8450. [CrossRef] [PubMed]
40. Kogo, R.; Shimamura, T.; Mimori, K.; Kawahara, K.; Imoto, S.; Sudo, T.; Tanaka, F.; Shibata, K.; Suzuki, A.; Komune, S., et al. Long Noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res. 2011, 71, 6320-6326. [CrossRef] [PubMed]
41. Bussemakers, M.J.; van Bokhoven, A.; Verhaegh, G.W.; Smit, F.P.; Karthaus, H.F.; Schalken, J.A.; Debruyne, F.M.; Ru, N.; Isaacs, W.B. DD3: A new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res. 1999, 59, 5975-5979. [PubMed]
42. Hessels, D.; Schalken, J.A. The use of PCA3 in the diagnosis of prostate cancer. Nat. Rev. Urol. 2009, 6, 255-261. [CrossRef] [PubMed]
43. De Kok, J.B.; Verhaegh, G.W.; Roelofs, R.W.; Hessels, D.; Kiemeney, L.A.; Aalders, T.W.; Swinkels, D.W.; Schalken, J.A. DD3(PCA3), a very sensitive and specific marker to detect prostate tumors. Cancer Res. 2002, 62, 2695-2698.
44. Srikantan, V.; Zou, Z.; Petrovics, G.; Xu, L.; Augustus, M.; Davis, L.; Livezey, J.R.; Connell, T.; Sesterhenn, I.A.; Yoshino, K., et al. PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer. Proc. Natl. Acad. Sci. USA 2000, 97, 12216-12221. [CrossRef]
45. Prensner, J.R.; Sahu, A.; Iyer, M.K.; Malik, R.; Chandler, B.; Asangani, I.A.; Poliakov, A.; Vergara, I.A.; Alshalalfa, M.; Jenkins, R.B., et al. The IncRNAs PCGEM1 and PRNCR1 are not implicated in castration resistant prostate cancer. Oncotarget 2014, 5, 1434-1438. [CrossRef] [PubMed]
46. Wang, X.-S.; Zhang, Z.; Wang, H.-C.; Cai, J.-L.; Xu, Q.-W.; Li, M.-Q.; Chen, Y.-C.; Qian, X.-P.; Lu, T.-J.; Yu, L.-Z., et al. Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma. Clin. Cancer Res. 2006, 12, 4851-4858. [CrossRef] [PubMed]
47. Srivastava, A.K.; Singh, P.K.; Rath, S.K.; Dalela, D.; Goel, M.M.; Bhatt, M.L.B. Appraisal of diagnostic ability of UCA1 as a biomarker of carcinoma of the urinary bladder. Tumor Biol. 2014, 35, 11435-11442. [CrossRef] [PubMed]
48. Weber, D.G.; Johnen, G.; Casjens, S.; Bryk, O.; Pesch, B.; Jöckel, K.-H.; Kollmeier, J.; Brüning, T. Evaluation of long noncoding RNA MALAT1 as a candidate blood-based biomarker for the diagnosis of non-small cell lung cancer. BMC Res. Notes 2013, 6. [CrossRef] [PubMed]
49. Svoboda, M.; Slyskova, J.; Schneiderova, M.; Makovicky, P.; Bielik, L.; Levy, M.; Lipska, L.; Hemmelova, B.; Kala, Z.; Protivankova, M., et al. HOTAIR long non-coding RNA is a negative prognostic factor not only in primary tumors, but also in the blood of colorectal cancer patients. Carcinogenesis 2014, 35, 1510-1515. [CrossRef] [PubMed]
50. Xue, W.-J.; Ying, X.-L.; Jiang, J.-H.; Xu, Y.-H. Prostate cancer antigen 3 as a biomarker in the urine for prostate cancer diagnosis: A meta-analysis. J. Cancer Res. Ther. 2014, 10, C218-C221. [CrossRef] [PubMed]
51. Merola, R.; Tomao, L.; Antenucci, A.; Sperduti, I.; Sentinelli, S.; Masi, S.; Mandoj, C.; Orlandi, G.; Papalia, R.; Guaglianone, S.; et al. PCA3 in prostate cancer and tumor aggressiveness detection on 407 high-risk patients: A National Cancer Institute experience. J. Exp. Clin. Cancer Res. 2015, 34, 15. [CrossRef] [PubMed]
52. Chevli, K.K.; Duff, M.; Walter, P.; Yu, C.; Capuder, B.; Elshafei, A.; Malczewski, S.; Kattan, M.W.; Jones, J.S. Urinary PCA3 as a predictor of prostate cancer in a cohort of 3,073 men undergoing initial prostate biopsy. J. Urol. 2014, 191, 1743-1748. [CrossRef] [PubMed]
53. Ren, S.; Wang, F.; Shen, J.; Sun, Y.; Xu, W.; Lu, J.; Wei, M.; Xu, C.; Wu, C.; Zhang, Z., et al. Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer. Eur. J. Cancer 2013, 49, 2949-2959. [CrossRef] [PubMed]
54. Tang, J.; Jiang, R.; Deng, L.; Zhang, X.; Wang, K.; Sun, B. Circulation long non-coding RNAs act as biomarkers for predicting tumorigenesis and metastasis in hepatocellular carcinoma. Oncotarget 2015, 6, 4505-4515. [CrossRef] [PubMed]
55. Shao, Y.; Ye, M.; Jiang, X.; Sun, W.; Ding, X.; Liu, Z.; Ye, G.; Zhang, X.; Xiao, B.; Guo, J. Gastric juice long noncoding RNA used as a tumor marker for screening gastric cancer. Cancer 2014, 120, 3320-3328. [CrossRef] [PubMed]
56. Li, Q.; Shao, Y.; Zhang, X.; Zheng, T.; Miao, M.; Qin, L.; Wang, B.; Ye, G.; Xiao, B.; Guo, J. Plasma long noncoding RNA protected by exosomes as a potential stable biomarker for gastric cancer. Tumor Biol. 2014, 36, 2007-2012. [CrossRef] [PubMed]
57. Xie, H.; Ma, H.; Zhou, D. Plasma HULC as a promising novel biomarker for the detection of hepatocellular carcinoma. BioMed Res. Int. 2013, 2013. [CrossRef] [PubMed]
58. Hu, B.; Yang, H.; Yang, H. Diagnostic value of urine prostate cancer antigen 3 test using a cutoff value of 35 _g/L in patients with prostate cancer. Tumor Biol. 2014, 35, 8573-8580. [CrossRef] [PubMed]
59. Lu, J.; Xie, F.; Geng, L.; Shen, W.; Sui, C.; Yang, J. Investigation of serum lncRNA-uc003wbd and lncRNA-AF085935 expression profile in patients with hepatocellular carcinoma and HBV. Tumor Biol. 2015, 36, 3231-3236. [CrossRef] [PubMed]
60. Tang, H.; Wu, Z.; Zhang, J.; Su, B. Salivary lncRNA as a potential marker for oral squamous cell carcinoma diagnosis. Mol. Med. Rep. 2013, 7, 761-766. [PubMed]
61. Nilsson, J.; Skog, J.; Nordstrand, A.; Baranov, V.; Mincheva-Nilsson, L.; Breakefield, X.O.; Widmark, A. Prostate cancer-derived urine exosomes: A novel approach to biomarkers for prostate cancer. Br. J. Cancer 2009, 100, 1603-1607. [CrossRef] [PubMed]
62. Huang, X.; Yuan, T.; Tschannen, M.; Sun, Z.; Jacob, H.; Du, M.; Liang, M.; Dittmar, R.L.; Liu, Y.; Liang, M., et al. Characterization of human plasma-derived exosomal RNAs by deep sequencing. BMC Genomics 2013, 14. [CrossRef] [PubMed]
63. Kogure, T.; Yan, I.K.; Lin, W.-L.; Patel, T. Extracellular vesicle-mediated transfer of a novel long noncoding RNA TUC339. Genes Cancer 2013, 4, 261-272. [CrossRef] [PubMed]
64. Lo Cicero, A.; Stahl, P.D.; Raposo, G. Extracellular vesicles shuffling intercellular messages: For good or for bad. Curr. Opin. Cell Biol. 2015, 35, 69-77. [CrossRef] [PubMed]
65. Lässer, C. Exosomes in diagnostic and therapeutic applications: Biomarker, vaccine and RNA interference delivery vehicle. Expert Opin. Biol. Ther. 2015, 15, 103-117. [CrossRef] [PubMed]
66. Bullock, M.D.; Silva, A.M.; Kanlikilicer-Unaldi, P.; Filant, J.; Rashed, M.H.; Sood, A.K.; Lopez-Berestein, G.; Calin, G.A. Exosomal non-coding RNAs: Diagnostic, prognostic and therapeutic applications in cancer. Non-Coding RNA 2015, 1, 53-68. [CrossRef]
67. Takahashi, K.; Yan, I.K.; Kogure, T.; Haga, H.; Patel, T. Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer. FEBS Open Bio. 2014, 4, 458-467. [CrossRef] [PubMed]
68. Conigliaro, A.; Costa, V.; Dico, A.L.; Saieva, L.; Buccheri, S.; Dieli, F.; Manno, M.; Raccosta, S.; Mancone, C.; Tripodi, M., et al. CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA. Mol. Cancer 2015, 14, 155. [CrossRef] [PubMed]
69. Isın, M.; Uysaler, E.; Özgür, E.; Köseoglu, H.; Sanlı, Ö.; Yücel, Ö.B.; Gezer, U.; Dalay, N. Exosomal lncRNA-p21 levels may help to distinguish prostate cancer from benign disease. Front. Genet. 2015, 6, 2-5.
70. Wang, J.; Zhou, Y.; Lu, J.; Sun, Y.; Xiao, H.; Liu, M.; Tian, L. Combined detection of serum exosomal miR-21 and HOTAIR as diagnostic and prognostic biomarkers for laryngeal squamous cell carcinoma. Med. Oncol. 2014, 31, 1-8. [CrossRef] [PubMed]
71. Arita, T.; Ichikawa, D.; Konishi, H.; Komatsu, S.; Shiozaki, A.; Shoda, K.; Kawaguchi, T.; Hirajima, S.; Nagata, H.; Kubota, T.; et al. Circulating long non-coding RNAs in plasma of patients with gastric cancer. Anticancer Res. 2013, 33, 3185-3193. [PubMed]
72. Huang, J.-L.; Zheng, L.; Hu, Y.-W.; Wang, Q. Characteristics of long non-coding RNA and its relation to hepatocellular carcinoma. Carcinogenesis 2014, 35, 507-514. [CrossRef] [PubMed]
73. Roberts, M.J.; Chow, C.W.K.; Schirra, H.J.; Richards, R.; Buck, M.; Selth, L.A.; Doi, S.A.R.; Samaratunga, H.; Perry-Keene, J.; Payton, D., et al. Diagnostic performance of expression of PCA3, Hepsin and miR biomarkers in ejaculate in combination with serum PSA for the detection of prostate cancer. Prostate 2015, 75, 539-549. [CrossRef] [PubMed]
74. Wu, Y.; Liu, J.; Zheng, Y.; You, L.; Kuang, D.; Liu, T. Suppressed expression of long non-coding RNA HOTAIR inhibits proliferation and tumourigenicity of renal carcinoma cells. Tumor Biol. 2014, 35, 11887-11894. [CrossRef] [PubMed]
75. Gutschner, T.; Hämmerle, M.; Eissmann, M.; Hsu, J.; Kim, Y.; Hung, G.; Revenko, A.; Arun, G.; Stentrup, M.; Gross, M., et al. The non-coding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res. 2013, 73, 1180-1189. [CrossRef] [PubMed]
76. Pedram Fatemi, R.; Salah-Uddin, S.; Modarresi, F.; Khoury, N.; Wahlestedt, C.; Faghihi, M.A. Screening for small-molecule modulators of long noncoding RNA-protein interactions using alphascreen. J. Biomol. Screen. 2015, 20, 1132-1141. [CrossRef] [PubMed]
77. Hanna, N.; Ohana, P.; Konikoff, F.M.; Leichtmann, G.; Hubert, A.; Appelbaum, L.; Kopelman, Y.; Czerniak, A.; Hochberg, A. Phase 1/2a, dose-escalation, safety, pharmacokinetic and preliminary efficacy study of intratumoral administration of BC-819 in patients with unresectable pancreatic cancer. Cancer Gene Ther. 2012, 19, 374-381. [CrossRef] [PubMed]
78. Yarmishyn, A.A.; Kurochkin, I.V. Long noncoding RNAs: A potential novel class of cancer biomarkers. Front. Genet. 2015, 6, 145. [CrossRef] [PubMed]
79. Toiyama, Y.; Okugawa, Y.; Goel, A. DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer. Biochem. Biophys. Res. Commun. 2014, 455, 43-57. [CrossRef] [PubMed]
80. Mäbert, K.; Cojoc, M.; Peitzsch, C.; Kurth, I.; Souchelnytskyi, S.; Dubrovska, A. Cancer biomarker discovery: Current status and future perspectives. Int. J. Radiat. Biol. 2014, 90, 659-677. [CrossRef] [PubMed]
81. Wang, X.; Li, M.; Wang, Z.; Han, S.; Tang, X.; Ge, Y.; Zhou, L.; Zhou, C.; Yuan, Q.; Yang, M. Silencing of long noncoding RNA MALAT1 by miR-101 and miR-217 inhibits proliferation, migration, and invasion of esophageal squamous cell carcinoma cells. J. Biol. Chem. 2015, 290, 3925-3935. [CrossRef] [PubMed]